Podrini, Christine http://orcid.org/0000-0002-5391-3378
Rowe, Isaline
Pagliarini, Roberto
Costa, Ana S. H. http://orcid.org/0000-0001-8932-6370
Chiaravalli, Marco
Di Meo, Ivano http://orcid.org/0000-0002-4616-5623
Kim, Hyunho
Distefano, Gianfranco
Tiranti, Valeria http://orcid.org/0000-0002-3584-7338
Qian, Feng
di Bernardo, Diego
Frezza, Christian http://orcid.org/0000-0002-3293-7397
Boletta, Alessandra
Funding for this research was provided by:
PKD Foundation (187G14a/b)
Ministero della Salute (RF-2011-02351840, GR-2016-02364851)
Article History
Received: 27 July 2018
Accepted: 22 October 2018
First Online: 16 November 2018
Competing interests
: A.B., I.R., and M.C. are co-inventors on a pending patent for the use of glycolysis inhibitors in polycystic kidney disease (European patent application N. 13733319.1; US Patent application N. 14/413,280). A.B., I.R., and C.P. are also co-inventors on a pending patent for the use of multiple metabolic interventions in polycystic kidney disease (European patent application, undisclosed number-under secrecy). The remaining authors declare no competing interests.